The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis,Headache

当前位置： X-MOL 学术 › Headache › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The introduction of the CGRP monoclonal antibodies and their effect on the prescription patterns of chronic migraine preventive medications in a tertiary headache center: A retrospective, observational analysis
Headache ( IF 5 ) Pub Date : 2023-10-26 , DOI: 10.1111/head.14642
Leon S Moskatel ₁ , Anna Graber-Naidich ₂ , Zihuai He _{1,

2} , Niushen Zhang ₁

Affiliation

To determine the effect of the introduction of the calcitonin gene–related peptide monoclonal antibodies (CGRP mAbs) in 2018 on the prescribing of older medications for the prevention of chronic migraine.

中文翻译：